Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
A randomized single dose, drug-drug interaction study in healthy volunteers for VM - 1500
given alone or in combination with Raltegravir or Darunavir in a 3 arm approach. The parallel
design is used due to the long half life for VM-1500.